Lantern Pharma (LTRN) Exchange Rate Effect (2022 - 2026)

Lantern Pharma (LTRN) has reported Exchange Rate Effect for 5 consecutive years, with -$664.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Exchange Rate Effect fell 102.38% year-over-year to -$664.0; the trailing twelve-month figure through Jun 2026 stood at $19620.0 (up 196.59% YoY), and the FY2025 full-year result was $33426.0, up 167.46% from the prior year.
• Exchange Rate Effect declined to -$664.0 in Q2 2026 per LTRN's latest filing, from $17585.0 in the prior quarter.
• Across five years, Exchange Rate Effect topped out at $27925.0 in Q2 2025 and bottomed at -$67207.0 in Q4 2024.
• Historically, Exchange Rate Effect has averaged -$2126.1 across 5 years, with a median of $1008.5 in 2022.
• The sharpest annual moves came in 2024 and 2026: Exchange Rate Effect slumped 1296.36% in 2024, then surged 527.59% in 2026.
• Over 5 years, Exchange Rate Effect stood at $9901.0 in 2022, then sank by 148.61% to -$4813.0 in 2023, then plunged by 1296.36% to -$67207.0 in 2024, then jumped by 104.4% to $2960.0 in 2025, then sank by 122.43% to -$664.0 in 2026.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered -$664.0, $17585.0, and $2960.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.